BPC-157 + TB-500 Research Blend – 10 mg Total

BPC-157 + TB-500 Research Blend – 10 mg Total is a dual-peptide research formulation supplied in a single vial for controlled laboratory, analytical, and scientific investigations.

This research blend combines BPC-157 with TB-500-related peptide material, allowing researchers to investigate two distinct peptide systems within a combined laboratory formulation.

BPC-157 is a synthetic peptide commonly studied in experimental research involving cellular signaling and tissue-response-related pathways. TB-500 is commonly associated with thymosin beta-4-related research, including investigations of actin interactions, cytoskeletal processes, and cellular migration.

Combining these materials provides a research formulation suitable for appropriately designed experiments examining multi-peptide interactions and comparative biochemical responses.

This product is supplied exclusively for laboratory research and analytical purposes. It is not intended for human consumption, veterinary administration, diagnosis, or medical treatment.

Product Specifications

• Product name: BPC-157 + TB-500 Research Blend
• Compounds: BPC-157 and TB-500
• Total content: 10 mg per vial
• Compound category: Dual-peptide research blend
• Research focus: Multi-peptide signaling and comparative peptide research
• Documentation: Certificate of Analysis available
• Available quantities: 1, 3, 5, 10, or 20 vials
• Shipping origin: United States
• Delivery: Domestic US-to-US shipping
• Intended purpose: Laboratory research and analytical testing only

The exact BPC-157-to-TB-500 ratio should be confirmed from the product formulation and applicable batch-specific COA. A 10 mg total content statement alone does not establish how that quantity is divided between the two components.

Dual-Peptide Research Characteristics

The BPC-157 + TB-500 blend combines two research compounds associated with different areas of peptide investigation.

BPC-157 research commonly focuses on cellular signaling, peptide interactions, cellular-response pathways, and biochemical mechanisms associated with experimental tissue models.

TB-500-related research is commonly associated with thymosin beta-4-related peptide biology, including actin interactions, cytoskeletal organization, and cell-migration pathways.

A combined formulation can therefore be of interest for controlled laboratory studies examining how multiple peptide systems behave under the same experimental conditions.

Potential research areas include:

• Multi-peptide interaction studies
• Cellular signaling research
• Cell-migration pathways
• Cytoskeletal research
• Actin-related biochemical investigations
• Peptide-cell interactions
• Comparative peptide analysis
• Combined-compound characterization
• Analytical testing
• Stability and degradation studies
• Research method development

These areas describe subjects of scientific investigation only. They should not be interpreted as claims that this blend repairs injuries, accelerates healing, improves recovery, regenerates tissue, enhances athletic performance, or provides therapeutic benefits.

BPC-157 Research Component

BPC-157 is a synthetic peptide used in experimental laboratory research.

It has been investigated in preclinical research involving various cellular and biochemical processes. For a commercial research listing, however, it is important to distinguish experimental findings from established clinical effects.

This product therefore makes no claim that BPC-157 is approved or demonstrated to diagnose, treat, cure, or prevent any disease or injury.

Within this blend, BPC-157 provides one component for comparative and multi-peptide laboratory investigations.

TB-500 Research Component

TB-500 is commonly marketed and investigated in connection with thymosin beta-4-related peptide research.

Thymosin beta-4 research has included investigations involving actin and cellular migration. However, researchers should not automatically treat the terms TB-500 and full-length thymosin beta-4 as chemically interchangeable.

The exact identity and specifications of the TB-500 component should be established using the batch-specific Certificate of Analysis and product documentation.

This distinction is particularly important when comparing experimental results with published literature involving thymosin beta-4.

Combined Peptide Research

The primary distinguishing characteristic of this product is that BPC-157 and TB-500 research materials are supplied together within a single formulation.

This may be useful for appropriately designed laboratory investigations involving:

• Combined peptide characterization
• Multi-compound analytical testing
• Comparative signaling studies
• Peptide stability analysis
• Controlled interaction experiments
• Repeat experimental series
• Analytical method development

Researchers should account for the presence of both compounds when designing controls and interpreting experimental results.

COA-Confirmed Research Material

BPC-157 + TB-500 Research Blend – 10 mg is supplied with access to batch-specific Certificate of Analysis (COA) documentation.

Depending on the testing performed for the applicable batch, documentation may include:

• Compound identification
• BPC-157 identification
• TB-500 component identification
• Batch or lot number
• Stated formulation
• Tested purity
• Analytical testing methodology
• Laboratory test date
• Reported analytical results

Researchers should review the applicable COA before beginning an experiment.

The batch-specific documentation should be considered the controlling source for the exact identity, composition, ratio, specifications, and analytical results associated with an individual lot.

Available Multi-Vial Options

BPC-157 + TB-500 Research Blend – 10 mg is available in several quantity options:

• 1 Vial – Regular Price
• 3 Vials – 5% OFF
• 5 Vials – 10% OFF ★ Most Popular ★
• 10 Vials – 15% OFF
• 20 Vials – 20% OFF

Each vial contains 10 mg total research material, distributed between BPC-157 and TB-500 according to the specified formulation.

Multi-vial packages provide a lower effective price per vial and may be suitable for projects requiring multiple samples, replicate experiments, comparative testing, or larger quantities from the same product specification.

Storage and Laboratory Handling

Store the BPC-157 + TB-500 research blend according to the conditions specified on the product label, packaging, and applicable batch documentation.

General laboratory precautions include:

• Keep the vial securely sealed until required
• Protect the material from excessive heat and direct light
• Avoid unnecessary temperature fluctuations
• Protect against moisture and contamination
• Use clean laboratory equipment and appropriate handling procedures
• Maintain accurate batch and lot records
• Document storage conditions and handling history
• Follow batch-specific storage requirements
• Minimize unnecessary handling

Exact storage requirements should always be confirmed using the documentation supplied with the applicable batch.

Laboratory Use and Research Responsibility

BPC-157 + TB-500 Research Blend – 10 mg should be handled by qualified individuals familiar with laboratory procedures and peptide research.

The purchaser is responsible for appropriate acquisition, storage, handling, documentation, experimental use, and disposal in accordance with applicable regulations and institutional requirements.

BuyGenerics does not provide instructions for personal administration, dosage recommendations, injection protocols, clinical treatment, injury recovery, athletic-performance use, or therapeutic applications.

Domestic US Shipping

BPC-157 + TB-500 Research Blend – 10 mg is available with domestic US-to-US fulfillment.

Ordering benefits include fast domestic delivery, discreet packaging, tracked shipping options, multiple vial quantities, and quantity discounts of up to 20%.

Domestic fulfillment also avoids international customs processing associated with overseas shipments.

Shipping availability and delivery times may vary depending on destination, inventory availability, order size, and selected delivery service.

Frequently Asked Questions

What compounds are included in this research blend?

The formulation contains BPC-157 and TB-500 research material.

How much material is contained in each vial?

Each vial contains 10 mg total research material.

Does 10 mg mean 10 mg of each peptide?

Not necessarily. The 10 mg designation refers to the total stated content of the blend. The exact quantity of BPC-157 and TB-500 individually should be confirmed from the formulation and batch-specific COA.

Why combine BPC-157 and TB-500 in one research product?

A combined formulation allows appropriately designed laboratory investigations involving both peptide materials under the same experimental conditions, including comparative and multi-peptide analytical studies.

Is a Certificate of Analysis available?

Yes. Batch-specific Certificate of Analysis documentation is available. Researchers should review the applicable COA for exact composition, identity, specifications, and reported analytical results.

Can I purchase multiple vials?

Yes. Available package quantities include 1, 3, 5, 10, and 20 vials, with increasing quantity discounts.

Is this blend intended for human use?

No. This product is sold exclusively for laboratory research and analytical applications and is not intended for human consumption or administration.

Research-Use Disclaimer

BPC-157 + TB-500 Research Blend – 10 mg is intended exclusively for laboratory research, analytical testing, and scientific investigation.

This product is not for human consumption or administration, veterinary use, use as a dietary supplement, athletic or performance use, diagnosis, treatment, or prevention of disease.

Information presented on this product page is provided solely for product identification and research-catalog purposes. It does not constitute medical advice, prescribing information, dosage guidance, injection instructions, or instructions for administration.